{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:17:29Z","timestamp":1792282649907,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17H04195"],"award-info":[{"award-number":["17H04195"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H00527"],"award-info":[{"award-number":["20H00527"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004823","name":"Nagoya University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20lm0203005"],"award-info":[{"award-number":["JP20lm0203005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.omtn.2021.02.007","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:46:32Z","timestamp":1613436392000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS"],"prefix":"10.1016","volume":"24","author":[{"given":"Tomoki","family":"Hirunagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Tachikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel I.","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Mukthavaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya P.","family":"Karmali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmanabh","family":"Chivukula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genki","family":"Tohnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3394-9760","authenticated-orcid":false,"given":"Madoka","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2662-5717","authenticated-orcid":false,"given":"Manabu","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5253-8556","authenticated-orcid":false,"given":"Yohei","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-9311","authenticated-orcid":false,"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2021.02.007_bib1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.18.7.671","article-title":"Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait","volume":"18","author":"Kennedy","year":"1968","journal-title":"Neurology"},{"key":"10.1016\/j.omtn.2021.02.007_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2021.02.007_bib3","series-title":"Pathogenesis of Polyglutamine Diseases","author":"Sahashi","year":"2018"},{"key":"10.1016\/j.omtn.2021.02.007_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","article-title":"Polyglutamine Repeats in Neurodegenerative Diseases","volume":"14","author":"Lieberman","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.omtn.2021.02.007_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington\u2019s disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"issue":"R1","key":"10.1016\/j.omtn.2021.02.007_bib6","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1093\/hmg\/ddz138","article-title":"Recent advances in molecular therapies for neurological disease: triplet repeat disorders","volume":"28","author":"Gonzalez-Alegre","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.02.007_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/brain\/awz328","article-title":"Antisense oligonucleotide therapeutics in neurodegenerative diseases: the case of polyglutamine disorders","volume":"143","author":"Silva","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2021.02.007_bib8","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1093\/nar\/gku385","article-title":"Oligonucleotide-based strategies to combat polyglutamine diseases","volume":"42","author":"Fiszer","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.02.007_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nbt.1539","article-title":"Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs","volume":"27","author":"Hu","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2021.02.007_bib10","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1021\/bi101208k","article-title":"Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat","volume":"49","author":"Gagnon","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2021.02.007_bib11","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1093\/nar\/gkr156","article-title":"Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats","volume":"39","author":"Fiszer","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.02.007_bib12","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism","volume":"17","author":"Hu","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtn.2021.02.007_bib13","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1093\/nar\/gkt594","article-title":"RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression","volume":"41","author":"Liu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.02.007_bib14","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1021\/bi4014209","article-title":"Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions","volume":"52","author":"Aiba","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2021.02.007_bib15","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1021\/bi500610r","article-title":"Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs","volume":"53","author":"Hu","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2021.02.007_bib16","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1093\/hmg\/ddu349","article-title":"Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity","volume":"23","author":"Sun","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.02.007_bib17","doi-asserted-by":"crossref","first-page":"e0171127","DOI":"10.1371\/journal.pone.0171127","article-title":"The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain","volume":"12","author":"Datson","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtn.2021.02.007_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.omtn.2019.07.004","article-title":"Suppression of Mutant Protein Expression in SCA3 and SCA1 Mice Using a CAG Repeat-Targeting Antisense Oligonucleotide","volume":"17","author":"Kourkouta","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2021.02.007_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/01677063.2015.1073275","article-title":"Allele-selective suppression of mutant genes in polyglutamine diseases","volume":"29","author":"Liu","year":"2015","journal-title":"J.\u00a0Neurogenet."},{"key":"10.1016\/j.omtn.2021.02.007_bib20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","article-title":"The Biology of Huntingtin","volume":"89","author":"Saudou","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2021.02.007_bib21","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1172\/JCI83185","article-title":"Targeting CAG repeat RNAs reduces Huntington\u2019s disease phenotype independently of huntingtin levels","volume":"126","author":"Ru\u00e9","year":"2016","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtn.2021.02.007_bib22","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1038\/mtna.2013.36","article-title":"5\u2032 unlocked nucleic acid modification improves siRNA targeting","volume":"2","author":"Snead","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2021.02.007_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","article-title":"Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"35","author":"Katsuno","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2021.02.007_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2021.02.007_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nbd.2008.10.009","article-title":"CAG repeat lengths > or\u00a0=335 attenuate the phenotype in the R6\/2 Huntington\u2019s disease transgenic mouse","volume":"33","author":"Dragatsis","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2021.02.007_bib26","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","article-title":"Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington\u2019s disease","volume":"17","author":"Wang","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.02.007_bib27","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1038\/s41467-020-16318-1","article-title":"Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form","volume":"11","author":"Yang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2021.02.007_bib28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","article-title":"Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy","volume":"7","author":"Lieberman","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2021.02.007_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","article-title":"Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy","volume":"82","author":"Cortes","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2021.02.007_bib30","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1016\/j.bmc.2009.06.045","article-title":"UNA (unlocked nucleic acid): a flexible RNA mimic that allows engineering of nucleic acid duplex stability","volume":"17","author":"Langkjaer","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.omtn.2021.02.007_bib31","doi-asserted-by":"crossref","first-page":"11270","DOI":"10.1093\/nar\/gks907","article-title":"Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway","volume":"40","author":"Hu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.02.007_bib32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/d41586-018-05867-7","article-title":"Gene-silencing technology gets first drug approval after 20-year wait","volume":"560","author":"Ledford","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2021.02.007_bib33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.02.007_bib34","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid Nanoparticle Systems for Enabling Gene Therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.02.007_bib35","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1038\/mtna.2013.65","article-title":"Lipid nanoparticle delivery of sirna to silence neuronal gene expression in the brain","volume":"2","author":"Rungta","year":"2013","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2021.02.007_bib36","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1038\/mtna.2015.15","article-title":"Intraventricular delivery of siRNA nanoparticles to the central nervous system","volume":"4","author":"Shyam","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2021.02.007_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.omtn.2017.08.013","article-title":"Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce \u03b1-Synuclein Expression in a Model of Parkinson\u2019s Disease","volume":"9","author":"Helmschrodt","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2021.02.007_bib38","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/nar\/gkj439","article-title":"Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging","volume":"34","author":"Bartlett","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.02.007_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-5793(04)00017-1","article-title":"Long-lasting RNAi activity in mammalian neurons","volume":"558","author":"Omi","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtn.2021.02.007_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pneurobio.2012.05.007","article-title":"Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)","volume":"99","author":"Katsuno","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.omtn.2021.02.007_bib41","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1093\/hmg\/ddv300","article-title":"Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy","volume":"24","author":"Sahashi","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2021.02.007_bib42","doi-asserted-by":"crossref","first-page":"E1941","DOI":"10.1073\/pnas.1619653114","article-title":"Systemic delivery of factor IX messenger RNA for protein replacement therapy","volume":"114","author":"Ramaswamy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2021.02.007_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13041-020-0561-1","article-title":"Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs","volume":"13","author":"Onodera","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.omtn.2021.02.007_bib44","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1038\/s41467-019-12282-7","article-title":"Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy","volume":"10","author":"Iida","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2021.02.007_bib45","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1101\/gad.197418.112","article-title":"TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals","volume":"26","author":"Sahashi","year":"2012","journal-title":"Genes Dev."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:44:54Z","timestamp":1788540294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253121000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":45,"alternative-id":["S2162253121000421"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2021.02.007","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2021.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}